Lifemd (LFMD) Stock
Virtual clinic platform connecting patients with doctors. Here's the price, business snapshot, and what's worth knowing about Lifemd in October 2026.
LifeMD Inc (ticker LFMD) is a small‑cap healthcare company (market capitalisation approx. $277.9M) that operates in the virtual and hybrid medical services space. Investors should know it aims to connect patients with clinicians and related services via digital channels, with revenue typically coming from consultations, product sales or partnerships. Key potential drivers include continued telehealth adoption, chronic care management demand and partnerships or distribution expansion. Equally important are the risks: small‑cap stocks can be volatile, profitability may be uncertain, and regulatory or reimbursement changes can materially affect performance. This summary is for general, educational purposes only and is not personal financial advice. Values can rise and fall and returns are not guaranteed; investors should consider their own risk tolerance, time horizon and the company’s public filings before making decisions.
Lifemd (LFMD) Stock Forecast
Analyst price target, next 12 months
$9.78
+359.2% vs today's $2.13
Price range over the last 12 months
Close to its 12-month low
Analysts covering Lifemd have a consensus 12-month target of $9.78, above the current price of $2.13.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 26 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying LIFEMD INC's stock with a target price of $9.78, indicating strong growth potential.
Financial Health
LIFEMD INC shows strong revenue and cash flow, with high profit margins supporting its growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Growth drivers to watch
Telehealth adoption, chronic‑care demand and partnerships could support growth, though execution and competition mean outcomes may vary.
Financial position matters
As a small‑cap, cash flow, profitability and access to funding are important signals; weaker results can lead to rapid share price moves.
Regulation & reimbursement
Policy changes and payer coverage directly affect telehealth economics, so regulatory developments are worth monitoring.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.